Future research into the treatment of vitiligo: Where should our priorities lie? Results of the vitiligo priority setting partnership

British Journal of Dermatology

Volumn 164, Issue 3, 2011, Pages 530-536

  Eleftheriadou, V ^a   Whitton, M E ^b   Gawkrodger, D J ^c   Batchelor, J ^d   Corne, J ^b   Lamb, B ^b   Ersser, S ^e   Ravenscroft, J ^f   Thomas, K S ^a  

^a UNIVERSITY OF NOTTINGHAM   (United Kingdom)

^b Vitiligo Society   (United Kingdom)

^c ROYAL HALLAMSHIRE HOSPITAL   (United Kingdom)

^d ADDENBROOKE S HOSPITAL   (United Kingdom)

^e BOURNEMOUTH UNIVERSITY   (United Kingdom)

^f QUEEN S MEDICAL CENTRE   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

IMMUNOSUPPRESSIVE AGENT; INTERMEDIN DERIVATIVE;

ARTICLE; CONSULTATION; GENE THERAPY; HEALTH PRACTITIONER; HUMAN; MEDICAL RESEARCH; METHODOLOGY; PHOTOTHERAPY; PRIORITY JOURNAL; PROFESSIONAL PRACTICE; PSYCHOTHERAPY; PUBLIC RELATIONS; QUALITY OF LIFE; UNITED KINGDOM; VITILIGO; WORKSHOP;

BIOMEDICAL RESEARCH; HUMANS; RECURRENCE; VITILIGO;

EID: 79952417044     PISSN: 00070963     EISSN: 13652133     Source Type: Journal    
DOI: 10.1111/j.1365-2133.2010.10160.x     Document Type: Article

References (21)

1. Howitz J, Brodthagen H, Schwartz M, Thomsen K,. Prevalence of vitiligo. Epidemiological survey on the Isle of Bornholm, Denmark. Arch Dermatol 1977; 113: 47-52. (Pubitemid 8020128)
2. Boisseau-Garsaud AM, Garsaud P, Cales-Quist D, et al. Epidemiology of vitiligo in the French West Indies (Isle of Martinique). Int J Dermatol 2000; 39: 18-20. (Pubitemid 30113532)
3. Lerner AB, Nordlund JJ,. Vitiligo. What is it? Is it important? JAMA 1978; 239: 1183-7. (Pubitemid 8322008)
4. Porter J, Beuf AH, Lerner A, et al. Response to cosmetic disfigurement: patients with vitiligo. Cutis 1987; 39: 493-4. (Pubitemid 17089140)
5. Porter J, Beuf A, Nordlund JJ, et al. Personal responses of patients to vitiligo: the importance of the patient-physician interaction. Arch Dermatol 1978; 114: 1384-5. (Pubitemid 9019363)
6. Porter J, Beuf AH, Nordlund JJ, et al. Psychological reaction to chronic skin disorders: a study of patients with vitiligo. Gen Hosp Psychiatry 1979; 1: 73-7. (Pubitemid 10121519)
7. Papadopoulos L, Bor R, Legg C,. Coping with the disfiguring effects of vitiligo: a preliminary investigation into the effects of cognitive-behavioural therapy. Br J Med Psychol 1999; 72: 385-96. (Pubitemid 29465543)
8. Radtke MA, Schafer I, Gajur AI, et al. Clinical features and treatment outcomes of vitiligo from the patients' perspective: results of a national survey in Germany. Dermatology 2010; 220: 194-200.
9. Whitton M, Pinart M, Batchelor J, et al. Interventions for vitiligo. Cochrane Database Syst Rev 2010; 1: CD003263.
10. Chalmers I,. Well informed uncertainties about the effects of treatments. BMJ 2004; 328: 475-6. (Pubitemid 38293600)
11. James Lind Alliance. The James Lind Alliance Guidebook. Oxford: James Lind Alliance, 2010; 56. Available at: (last accessed 9 December 2010).
12. Buckley BS, Grant AM, Tincello DG, et al. Prioritizing research: patients, carers, and clinicians working together to identify and prioritize important clinical uncertainties in urinary incontinence. Neurourol Urodyn 2010; 29: 708-14.
13. NHS Evidence. UK Database of Uncertainties About the Effects of Treatments (DUETs). Available at: (last accessed 9 December 2010).
14. Lloyd K, Rose D, Fenton M,. Identifying uncertainties about the effects of treatments for schizophrenia. J Ment Health 2006; 15: 263-8. (Pubitemid 43995541)
15. Gawkrodger DJ, Ormerod AD, Shaw L, et al. Guideline for the diagnosis and management of vitiligo. Br J Dermatol 2008; 159: 1051-76.
16. Eleftheriadou V, Thomas K,. Have your say in research into vitiligo. Dermatolog Nurs 2009; 8: 56-7.
17. Eleftheriadou V,. Have your say in research into vitiligo (advertisement). Bull Prim Care Dermatol Soc 2009; 9: 1-7.
18. Elwyn G, Crowe S, Fenton M, et al. Identifying and prioritizing uncertainties: patient and clinician engagement in the identification of research questions. J Eval Clin Pract 2010; 16: 627-31.
19. Rezaei N, Gavalas NG, Weetman AP, et al. Autoimmunity as an aetiological factor in vitiligo. J Eur Acad Dermatol Venereol 2007; 21: 865-76. (Pubitemid 47103715)
20. Westerhof W, d'Ischia M,. Vitiligo puzzle: the pieces fall in place. Pigment Cell Res 2007; 20: 345-59. (Pubitemid 47390114)
21. NHS. INVOLVE: National Institute for Health Research. Available at: (last accessed 9 December 2010).